BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32114374)

  • 1. Agreement between questionnaires and registry data on routes to diagnosis and milestone dates of the cancer diagnostic pathway.
    Falborg AZ; Vedsted P; Menon U; Weller D; Neal RD; Reguilon I; Harrison S; Jensen H;
    Cancer Epidemiol; 2020 Apr; 65():101690. PubMed ID: 32114374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
    Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
    BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agreement between patient-reported and doctor-reported patient intervals and date of first symptom presentation in cancer diagnosis - a population-based questionnaire study.
    Larsen MB; Hansen RP; Sokolowski I; Vedsted P
    Cancer Epidemiol; 2014 Feb; 38(1):100-5. PubMed ID: 24238619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agreement between questionnaires and registry data on routes to diagnosis and milestone dates of the cancer diagnostic pathway; Methodological issues.
    Sabour S
    Cancer Epidemiol; 2020 Aug; 67():101741. PubMed ID: 32473791
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to the letter to the editor Re: "Agreement between questionnaires and registry data on routes to diagnosis and milestone dates of the cancer diagnostic pathway: Methodological issues".
    Falborg AZ
    Cancer Epidemiol; 2020 Aug; 67():101740. PubMed ID: 32487427
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of general practice in routes to diagnosis of lung cancer in Denmark: a population-based study of general practice involvement, diagnostic activity and diagnostic intervals.
    Guldbrandt LM; Fenger-Grøn M; Rasmussen TR; Jensen H; Vedsted P
    BMC Health Serv Res; 2015 Jan; 15():21. PubMed ID: 25608462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement between patients and general practitioners on quality deviations during the cancer diagnostic pathway and associations with time to diagnosis.
    Jensen H; Sperling C; Sandager M; Vedsted P
    Fam Pract; 2015 Jun; 32(3):329-35. PubMed ID: 25888583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of registry data: agreement between cancer records in an end-stage kidney disease registry (voluntary reporting) and a cancer register (statutory reporting).
    Webster AC; Supramaniam R; O'Connell DL; Chapman JR; Craig JC
    Nephrology (Carlton); 2010 Jun; 15(4):491-501. PubMed ID: 20609104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data.
    Setoguchi S; Solomon DH; Glynn RJ; Cook EF; Levin R; Schneeweiss S
    Cancer Causes Control; 2007 Jun; 18(5):561-9. PubMed ID: 17447148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using administrative data to estimate time to breast cancer diagnosis and percent of screen-detected breast cancers – a validation study in Alberta, Canada.
    Yuan Y; Li M; Yang J; Winget M
    Eur J Cancer Care (Engl); 2015 May; 24(3):367-75. PubMed ID: 25521706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000.
    Engholm G; Kejs AM; Brewster DH; Gaard M; Holmberg L; Hartley R; Iddenden R; Møller H; Sankila R; Thomson CS; Storm HH
    Int J Cancer; 2007 Sep; 121(5):1115-22. PubMed ID: 17455250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathway to diagnosis and treatment for surgically managed lung cancer patients.
    White V; Bergin RJ; Thomas RJ; Whitfield K; Weller D
    Fam Pract; 2020 Mar; 37(2):234-241. PubMed ID: 31665265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An automated algorithm for consolidating dates of diagnosis from multiple sources.
    Zhang X; Kahn AR; Boscoe FP; Buckley PM
    J Registry Manag; 2013; 40(1):36-9. PubMed ID: 23778696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK.
    Lachmann P
    Lancet; 2011 Apr; 377(9772):1149; author reply 1149-50. PubMed ID: 21459202
    [No Abstract]   [Full Text] [Related]  

  • 18. The Aarhus statement on cancer diagnostic research: turning recommendations into new survey instruments.
    Coxon D; Campbell C; Walter FM; Scott SE; Neal RD; Vedsted P; Emery J; Rubin G; Hamilton W; Weller D
    BMC Health Serv Res; 2018 Sep; 18(1):677. PubMed ID: 30176861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms.
    Pearson C; Poirier V; Fitzgerald K; Rubin G; Hamilton W
    BMJ Open; 2020 Jan; 10(1):e033008. PubMed ID: 31924638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perspectives on delays in diagnosis and treatment of cancer: a qualitative analysis of free-text data.
    Parsonage RK; Hiscock J; Law RJ; Neal RD
    Br J Gen Pract; 2017 Jan; 67(654):e49-e56. PubMed ID: 27872084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.